Evidence map›Paper›PMID 36768456›Full record

ArticleInternational journal of molecular sciences2023

Tachykinin Receptor-Selectivity of the Potential Glioblastoma-Targeted Therapy, DOTA-[Thi

Janine Suthiram, Ané Pieters, Zulfiah Mohamed Moosa, Jan Rijn Zeevaart, Mike M Sathekge, Thomas Ebenhan, Ross C Anderson, Claire L Newton

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Glioma and Peptidergic Systems: Oncogenic and Anticancer Peptides.International journal of molecular sciences · 2024
    Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Janine SuthiramDepartment of Radiochemistry, The South African Nuclear Energy Corporation SOC Ltd. (Necsa), Brits 0240, South Africa.ORCID 0000-0002-5330-6244
Ané PietersDepartment of Physiology, Faculty of Health Sciences, University of Pretoria, Private Bag X323, Gezina 0031, South Africa.
Zulfiah Mohamed MoosaDepartment of Physiology, Faculty of Health Sciences, University of Pretoria, Private Bag X323, Gezina 0031, South Africa.ORCID 0000-0003-4671-2997
Jan Rijn ZeevaartDepartment of Radiochemistry, The South African Nuclear Energy Corporation SOC Ltd. (Necsa), Brits 0240, South Africa.ORCID 0000-0003-0794-3012
Mike M SathekgeDepartment of Nuclear Medicine, Faculty of Health Sciences, University of Pretoria, Private Bag X323, Gezina 0031, South Africa.ORCID 0000-0002-2806-0625
Thomas EbenhanDepartment of Nuclear Medicine, Faculty of Health Sciences, University of Pretoria, Private Bag X323, Gezina 0031, South Africa.
Ross C AndersonDepartment of Physiology, Faculty of Health Sciences, University of Pretoria, Private Bag X323, Gezina 0031, South Africa.ORCID 0000-0001-6742-1238
Claire L NewtonCentre for Neuroendocrinology, Department of Immunology, Faculty of Health Sciences, University of Pretoria, Private Bag X323, Gezina 0031, South Africa.ORCID 0000-0001-6050-556X

Funding

Technology Innovation Agency South Africa Seed Funding Award to JS
6 · The paper itself

Abstract

Radiopharmaceutical development hinges on the affinity and selectivity of the biological component for the intended target. An analogue of the neuropeptide Substance P (SP), 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-[Thi

Indexed as

GlioblastomaSubstance PHEK293 CellsHeterocyclic Compounds, 1-RingHumansNerve Tissue ProteinsReceptors, G-Protein-CoupledReceptors, Neurokinin-1Receptors, Neurokinin-2Receptors, NeuropeptideReceptors, Tachykinin1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidHeterocyclic Compounds, 1-RingMRGPRX2 protein, humanNerve Tissue ProteinsReceptors, G-Protein-CoupledReceptors, Neurokinin-1Receptors, Neurokinin-2Receptors, NeuropeptideReceptors, TachykininSubstance PDOTA-[Thi8,Met(O2)11]SPglioblastoma multiformemas-related G protein-coupled receptor subtype 2neurokinin-1 receptorneurokinin-2 receptorneurokinin-3 receptorreceptor selectivitytheranostics

Identifiers

PMID36768456
PMCPMC9916806

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.